Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

BACKGROUND: Patients with chronic hepatitis B virus (HBV) infection who are hepatitis B virus e antigen (HBeAg) positive are increasingly being treated with nucleos(t)ide analogs (NUCs). However, the predictive value of serum hepatitis B virus core antibody (HBcAb) levels for HBeAg seroconversion am...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Shaohang, Li, Zhandong, Yu, Tao, Xia, Muye, Peng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892618/
https://www.ncbi.nlm.nih.gov/pubmed/29662321
http://dx.doi.org/10.2147/IDR.S163038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892618/
https://www.ncbi.nlm.nih.gov/pubmed/29662321
http://dx.doi.org/10.2147/IDR.S163038

Ejemplares similares